Funded Tech Companies
PhaseBio Pharmaceuticals
PhaseBio Pharmaceuticals is a biopharmaceutical company, located in Malvern. Financial backing came from AstraZeneca, Johnson & Johnson Development Corporation and Syno Capital.
Company Overview
Company Name
PhaseBio Pharmaceuticals
Company Status
Publicly-held
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
1 Great Valley Pkwy. 30
Malvern, PA 19355
USA
Malvern, PA 19355
USA
Phone
Website
Email Address
Not Recorded
Company Background Information
Overview
PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), located in Malvern, PA, is a development stage, privately held protein engineering company focused on developing the next generation of biopharmaceuticals.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
10/17/2018
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jonathan Mow
Chief Financial Officer
John Sharp
Chief Medical Officer
John Lee
VP - Bus. Development
Susan Arnold
VP - Bus. Development
Michael York
VP - R & D
James Ballance
Company Investors
- AstraZeneca (Michael Gutch)
- Johnson & Johnson Development Corporation
- Syno Capital
- New Enterprise Associates (James Barrett)
- Hatteras Venture Partners (Clay Thorp)
- Rock Springs Capital
- Mountain Group Capital
- Fletcher Spaght Ventures (Guy Fish)
- Cormorant Asset Management
- Silicon Valley Bank (Scott McCarty)
- Astellas Venture Capital
- Johnson & Johnson Development Corporation (Asish Xavier)
Browse more funded tech companies:
Share this article
About Our VC Transaction Database
This tech company profile is powered by VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs